Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Evozyneevozyne.com · Low evidenceEvozyne uses generative AI to design novel therapeutic proteins for immune-mediated diseases, creating mechanisms not found in nature. The company's platform accelerates development from concept to clinic, focusing on conditions where current biologics and small molecules fail.
Parse Score